UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Intestinal Absorption of a Prodrug of the mGlu2/3 Receptor Agonist LY354740 is Mediated by PEPT1: In Situ Rat Intestinal Perfusion Studies

Journal of pharmaceutical sciences, 2010-03, Vol.99 (3), p.1574-1581

2010

Volltextzugriff (PDF)

An integrated PK‐PD model for cortisol and the 17‐hydroxyprogesterone and androstenedione biomarkers in children with congenital adrenal hyperplasia

British journal of clinical pharmacology, 2021-03, Vol.87 (3), p.1098-1110

2021

Volltextzugriff (PDF)

Transepithelial transport of the group II metabotropic glutamate 2/3 receptor agonist (1S,2S,5R,6S)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylate (LY354740) and its prodrug (1S,2S,5R,6S)-2-[(2'S)-(2'-amino)propionyl]aminobicyclo[3.1.0]hexane-2,6-dicarboxylate (LY544344)

Drug metabolism and disposition, 2009-01, Vol.37 (1), p.211-220

2009

Volltextzugriff (PDF)

Interrelationships Among Cortisol, 17-Hydroxyprogesterone, and Androstenendione Exposures in the Management of Children With Congenital Adrenal Hyperplasia

Journal of investigative medicine, 2015-01, Vol.63 (1), p.35-41

2015

Volltextzugriff (PDF)

Comparison of cortisol exposures and pharmacodynamic adrenal steroid responses to hydrocortisone suspension vs. commercial tablets

Journal of clinical pharmacology, 2015-04, Vol.55 (4), p.452-457

2015

Volltextzugriff (PDF)

In vivo-formed versus preformed metabolite kinetics of trans-resveratrol-3-sulfate and trans-resveratrol-3-glucuronide

Drug metabolism and disposition, 2012-10, Vol.40 (10), p.1993-2001

2012

Volltextzugriff (PDF)

Metabolism of opioids is altered in liver microsomes of sickle cell transgenic mice

Drug metabolism and disposition, 2004-01, Vol.32 (1), p.98-104

2004

Volltextzugriff (PDF)

CK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumors

Oncotarget, 2016-09, Vol.7 (38), p.61789-61805

2016

Volltextzugriff (PDF)

Phenanthrene metabolism in smokers: use of a two-step diagnostic plot approach to identify subjects with extensive metabolic activation

The Journal of pharmacology and experimental therapeutics, 2012-09, Vol.342 (3), p.750-760

2012

Volltextzugriff (PDF)

Intestinal metabolism: the role of enzyme localization in phenol metabolite kinetics

Drug metabolism and disposition, 2002-05, Vol.30 (5), p.586-594

2002

Volltextzugriff (PDF)

Formation and distribution of NNK metabolites in an isolated perfused rat lung

Drug metabolism and disposition, 2010-05, Vol.38 (5), p.752-760

2010

Volltextzugriff (PDF)

Pharmacokinetics of Amino Acid Phosphoramidate Monoesters of Zidovudine in Rats

Antimicrobial Agents and Chemotherapy, 2002-05, Vol.46 (5), p.1357-1363

2002

Volltextzugriff (PDF)

Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen

JNCI : Journal of the National Cancer Institute, 2004-01, Vol.96 (2), p.107-115

2004

Volltextzugriff (PDF)

Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation

Cancer research (Chicago, Ill.), 1999-02, Vol.59 (3), p.590-596

1999

Volltextzugriff (PDF)

Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use

Cancer research (Chicago, Ill.), 2002, Vol.62 (1), p.129-134

2002

Volltextzugriff (PDF)

Stereoselective metabolism and tissue retention in rats of the individual enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), metabolites of the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)

Carcinogenesis (New York), 2004-07, Vol.25 (7), p.1237-1242

2004

Volltextzugriff (PDF)

Metabolism and pharmacokinetics of N'-nitrosonornicotine in the patas monkey

Drug metabolism and disposition, 2002-10, Vol.30 (10), p.1115-1122

2002

Volltextzugriff (PDF)

Disposition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in bile duct-cannulated rats: Stereoselective metabolism and tissue distribution

Carcinogenesis (New York), 2002-01, Vol.23 (1), p.171-179

2002

Volltextzugriff (PDF)

Disposition and oral bioavailability in rats of an antiviral and antitumor amino acid phosphoramidate prodrug of AZT-monophosphate

Pharmaceutical research, 2003-03, Vol.20 (3), p.448-451

2003

Volltextzugriff (PDF)

First-pass disposition of (-)-6-aminocarbovir in rats: II. Inhibition of intestinal first-pass metabolism

Drug metabolism and disposition, 2000-06, Vol.28 (6), p.672

2000

Volltextzugriff (PDF)

Methotrexate accumulates to similar levels in animals transplanted with normal versus drug-resistant transgenic marrow

Cancer research (Chicago, Ill.), 2001-02, Vol.61 (4), p.1522-1526

2001

Volltextzugriff (PDF)

The intestinal uptake of phenol from micellar systems does not conform to the aqueous transfer model

Pharmaceutical research, 2000-07, Vol.17 (7), p.839-843

2000

Volltextzugriff (PDF)

Use of the deconvolution principle in the estimation of absorption and pre-systemic intestinal elimination of drugs

Drug metabolism and disposition, 1997-11, Vol.25 (11), p.1260

1997

Volltextzugriff (PDF)

The absorption of retinoic acids from the gastrointestinal tract is dependent upon chemical structure

Cancer chemotherapy and pharmacology, 2001, Vol.47 (1), p.27-33

2001

Volltextzugriff (PDF)

Abstract 1696: Metabolism of (S)- NNAL and (R)- NNAL in the isolated perfused rat lung system

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.1696-1696

2010

Volltextzugriff (PDF)

1 – 25 von 105

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(80)

Publikationsform

Artikel
(103)
Bücher
(1)
Reviews
(1)

Sprache

Englisch
(105)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Intestinal Absorption of a Prodrug of the mGlu2/3 Receptor Agonist LY354740 is Mediated by PEPT1: In Situ Rat Intestinal Perfusion Studies

An integrated PK‐PD model for cortisol and the 17‐hydroxyprogesterone and androstenedione biomarkers in children with congenital adrenal hyperplasia

Transepithelial transport of the group II metabotropic glutamate 2/3 receptor agonist (1S,2S,5R,6S)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylate (LY354740) and its prodrug (1S,2S,5R,6S)-2-[(2'S)-(2'-amino)propionyl]aminobicyclo[3.1.0]hexane-2,6-dicarboxylate (LY544344)

Interrelationships Among Cortisol, 17-Hydroxyprogesterone, and Androstenendione Exposures in the Management of Children With Congenital Adrenal Hyperplasia

Comparison of cortisol exposures and pharmacodynamic adrenal steroid responses to hydrocortisone suspension vs. commercial tablets

In vivo-formed versus preformed metabolite kinetics of trans-resveratrol-3-sulfate and trans-resveratrol-3-glucuronide

Metabolism of opioids is altered in liver microsomes of sickle cell transgenic mice

CK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumors

Phenanthrene metabolism in smokers: use of a two-step diagnostic plot approach to identify subjects with extensive metabolic activation

Intestinal metabolism: the role of enzyme localization in phenol metabolite kinetics

Formation and distribution of NNK metabolites in an isolated perfused rat lung

Pharmacokinetics of Amino Acid Phosphoramidate Monoesters of Zidovudine in Rats

Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen

Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation

Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use

Stereoselective metabolism and tissue retention in rats of the individual enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), metabolites of the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)

Metabolism and pharmacokinetics of N'-nitrosonornicotine in the patas monkey

Disposition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in bile duct-cannulated rats: Stereoselective metabolism and tissue distribution

Disposition and oral bioavailability in rats of an antiviral and antitumor amino acid phosphoramidate prodrug of AZT-monophosphate

First-pass disposition of (-)-6-aminocarbovir in rats: II. Inhibition of intestinal first-pass metabolism

Methotrexate accumulates to similar levels in animals transplanted with normal versus drug-resistant transgenic marrow

The intestinal uptake of phenol from micellar systems does not conform to the aqueous transfer model

Use of the deconvolution principle in the estimation of absorption and pre-systemic intestinal elimination of drugs

The absorption of retinoic acids from the gastrointestinal tract is dependent upon chemical structure

Abstract 1696: Metabolism of (S)- NNAL and (R)- NNAL in the isolated perfused rat lung system

Suchergebnisse filtern